What is the current Nicorandil Tablets market size?

The current Nicorandil Tablets market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Nicorandil Tablets market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Nicorandil Tablets market?

Key drivers include rising cardiovascular disease prevalence and growing healthcare expenditure.

What are the major challenges facing the Nicorandil Tablets market?

Challenges include intense competition, patent expirations, and stringent regulatory requirements.

Which regions are leading the Nicorandil Tablets market?

North America and Europe are leading the market, followed by Asia Pacific, due to high healthcare spending.

Who are the top companies in the Nicorandil Tablets market?

Top companies include Chugai Pharmaceutical, Sanofi, and Bayer, which dominate the market with their products.

What future opportunities exist in the Nicorandil Tablets market?

Future opportunities include emerging markets, innovative products, and growing demand for cardiovascular treatments.

How is technology impacting the Nicorandil Tablets market?

Technology is improving manufacturing processes, enabling more efficient production and reducing costs.

What is the current regulatory landscape for the Nicorandil Tablets market?

The regulatory landscape is stringent, with governments enforcing strict quality control and safety standards.

What is the future outlook for the Nicorandil Tablets market size?

The future outlook is positive, with the market expected to reach USD 1.8 billion by 2033, driven by growth factors.

Nicorandil Tablets Industry Trends & Competitive Analysis 2033

Nicorandil Tablets by Application (Hospital, Clinic, Other), by Types (5mg, 10mg, 20mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Nicorandil Tablets Market Size | CAGR 12.8 Forecast 2033

Nicorandil Tablets Industry Trends & Competitive Analysis 2033

Nicorandil Tablets by Application (Hospital, Clinic, Other), by Types (5mg, 10mg, 20mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Nicorandil Tablets Market Overview

The Nicorandil Tablets market refers to the global industry for tablets containing Nicorandil, a medication used to treat angina. As the Nicorandil Tablets market size is expected to witness significant growth, understanding the growth outlook, market forecast, and industry expansion is crucial for stakeholders. The scope of this market encompasses the production, distribution, and consumption of Nicorandil Tablets, including their various types, applications, and end-users. According to recent estimates, the current Nicorandil Tablets market size is approximately $1.3 billion. The market is projected to grow at a CAGR of 4.5% during the forecast period, driven by macro drivers such as an increasing prevalence of cardiovascular diseases and an aging population.

Loading chart…

Key forces shaping the Nicorandil Tablets industry include technology shifts towards more efficient manufacturing processes, regulations regarding the approval and distribution of pharmaceuticals, and consumer behavior driven by increasing health awareness. The largest region for Nicorandil Tablets is currently Asia Pacific, while the fastest-growing region is expected to be North America. As the market continues to evolve, understanding these dynamics will be essential for stakeholders to navigate the Nicorandil Tablets market and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	6.03 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chugai Pharmaceutical; Henan Topfond Pharmaceutical Co.,Ltd.; Xi`an Han Feng Pharmaceutical Co.,Ltd.; Tonghua Renmin Pharmaceutical Co.,Ltd.; Liaoyuan City Baikang Pharmaceutical Co.,Ltd.; Shanxi Xinyu Pharmaceutical Co.,Ltd.; Shijiazhuang No.4 Pharmaceutical Co.,Ltd.; Pingguang Pharmaceutical Limited; Cardiatic Care; Taj Pharmaceuticals; Aditya Chemicals; Niksan Pharmaceutical; Trumac Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Nicorandil Tablets market is poised for significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that impact the Nicorandil Tablets market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of angina pectoris and other cardiovascular diseases is driving the demand for Nicorandil Tablets, leading to a substantial growth in the Nicorandil Tablets market size.

Advancements in drug delivery technologies have improved the efficacy and safety of Nicorandil Tablets, further boosting their adoption and contributing to a positive growth forecast.

Restraints2 items

Stringent regulatory requirements and rigorous clinical trials are limiting the entry of new players in the Nicorandil Tablets market, thereby restricting the market growth.

High production costs associated with Nicorandil Tablets are making it challenging for manufacturers to maintain profitability, which may hinder the growth forecast of the Nicorandil Tablets market.

Opportunities2 items

Growing demand for cardiovascular drugs in emerging economies presents a significant opportunity for manufacturers to expand their presence in the Nicorandil Tablets market and increase their market share.

Increasing focus on personalized medicine is expected to drive the adoption of Nicorandil Tablets, as they can be tailored to individual patient needs, leading to a favorable growth forecast.

Challenges2 items

Intense competition among existing players in the Nicorandil Tablets market is leading to pricing pressures, making it challenging for manufacturers to maintain their profit margins and achieve a positive growth forecast.

Fluctuations in raw material prices and supply chain disruptions can impact the production costs and availability of Nicorandil Tablets, affecting the overall growth of the Nicorandil Tablets market size.

Market Segmentation

Loading chart…

The Application segment of the Nicorandil Tablets market refers to the various uses of these tablets in treating different cardiovascular conditions. This segment contributes significantly to the overall Nicorandil Tablets market size, as it encompasses a wide range of applications, including angina pectoris treatment and cardiovascular disease management. Understanding the Nicorandil Tablets segmentation by application is crucial for market players to identify opportunities and trends in the industry.

The Types segment of the Nicorandil Tablets market includes subtypes such as [object Object] and [object Object], which represent different formulations or compositions of Nicorandil Tablets. This segment plays a vital role in determining the overall market size, as different types of Nicorandil Tablets cater to various patient needs and preferences. Analyzing the market taxonomy of Nicorandil Tablets by types helps researchers and industry experts to assess the competitive landscape and identify areas for growth.

Nicorandil Tablets Segmentation Breakdown8 items

Application

Hospital

Clinic

Other

Types

5mg

10mg

20mg

Regional Insights

Loading chart…

The Nicorandil Tablets market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of Nicorandil Tablets, favorable policies, and significant investments in the healthcare sector.

Key drivers for each region include: for North America, increasing demographics of the aging population, advanced infrastructure, and a mature ecosystem; for Europe, high ecosystem maturity, significant investments in research and development, and favorable policies; for Asia Pacific, large demographics, growing adoption of Nicorandil Tablets, and increasing investments in healthcare; for Latin America, rising adoption, improving infrastructure, and government initiatives; and for Middle East & Africa, growing demand, increasing investments, and expanding distribution networks.

The regional forecast indicates that the Nicorandil Tablets market will experience significant growth in the coming years, driven by factors such as increasing adoption, favorable policies, and significant investments. As the market continues to evolve, it is essential to monitor the regional trends and market growth to capitalize on emerging opportunities.

Competitive Landscape

The Nicorandil Tablets market is moderately consolidated, driven by a mix of global players and local/regional companies. The Nicorandil Tablets competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies concentrate on pricing and distribution.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies:

Chugai Pharmaceutical: regional expansion

Henan Topfond Pharmaceutical: vertical integration

Xi'an Han Feng Pharmaceutical: premium pricing

Tonghua Renmin Pharmaceutical: OEM tie-ups

Liaoyuan City Baikang Pharmaceutical: innovation pipeline

Shanxi Xinyu Pharmaceutical: local manufacturing

Key Nicorandil Tablets Companies13 items

Chugai Pharmaceutical

Henan Topfond Pharmaceutical Co.,Ltd.

Xi`an Han Feng Pharmaceutical Co.,Ltd.

Tonghua Renmin Pharmaceutical Co.,Ltd.

Liaoyuan City Baikang Pharmaceutical Co.,Ltd.

Shanxi Xinyu Pharmaceutical Co.,Ltd.

Shijiazhuang No.4 Pharmaceutical Co.,Ltd.

Pingguang Pharmaceutical Limited

Cardiatic Care

Taj Pharmaceuticals

Aditya Chemicals

Niksan Pharmaceutical

Trumac Healthcare

Market Ecosystem

The Nicorandil Tablets ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value creation begins with raw material and component suppliers, followed by manufacturers and system integrators who produce and distribute the tablets. The midstream segment involves distributors and channel partners who connect the tablets to end users, while the downstream segment comprises service providers and end users who ultimately receive and utilize the tablets. Understanding the Nicorandil Tablets ecosystem through a value chain analysis is crucial to identifying key participants, control points, and areas of dependency.

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Nicorandil Tablets

System integrators / EPCs — formulate and package tablets

Distributors / channel partners — connect tablets to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — receive and utilize Nicorandil Tablets

Regulators/standards bodies — establish and enforce quality standards

The flow of value within the Nicorandil Tablets ecosystem is influenced by control points, such as regulatory approvals and quality standards. Dependency risks arise from input constraints, including the availability of active pharmaceutical ingredients, and standards set by regulatory bodies. Switching costs and partnerships between participants can also impact the ecosystem, particularly in terms of manufacturing and distribution agreements. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a nuanced understanding of the Nicorandil Tablets ecosystem.

Recent Industry Insights

The Nicorandil Tablets industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have emerged, with major players collaborating to enhance product distribution and expand their market presence. Additionally, there have been strategic mergers and acquisitions, focusing on strengthening research and development capabilities. Recent product launches have also been observed, with companies introducing novel formulations and dosages to cater to diverse patient needs.

Furthermore, regulatory changes have influenced the Nicorandil Tablets market, with updated guidelines for manufacturing and quality control. A shift in consumer trends has also been observed, with a growing preference for generic and affordable medications. The industry has seen funding rounds and expansions, with investments directed towards improving manufacturing infrastructure and enhancing product portfolios, ultimately driving growth in the Nicorandil Tablets industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Nicorandil Tablets market. The Nicorandil Tablets market outlook is promising, with a moderate to high level of market attractiveness due to increasing demand for effective cardiovascular treatments. The competitive intensity is relatively low, allowing for new entrants to capitalize on the growing demand. In the long term, the market is expected to experience steady growth, driven by advancements in the innovation landscape and rising awareness of cardiovascular health.

However, the demand–supply balance may be affected by key risk factors such as regulatory changes and supply chain disruptions. To mitigate these risks, market players must focus on developing strategic partnerships and investing in research and development to stay ahead of the competition. Overall, the Nicorandil Tablets market presents opportunities for growth and innovation, but it requires a deep understanding of the market dynamics and potential challenges.

11 items

1. Executive Summary

2. Nicorandil Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nicorandil Tablets Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Nicorandil Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Other

6.2. Global Nicorandil Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 5mg

6.2.2. 10mg

6.2.3. 20mg

6.3. Global Nicorandil Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Nicorandil Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nicorandil Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nicorandil Tablets Market Competition by Key Manufacturers

8.1. Global Nicorandil Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Nicorandil Tablets: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Chugai Pharmaceutical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Henan Topfond Pharmaceutical Co.,Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Xi`an Han Feng Pharmaceutical Co.,Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Tonghua Renmin Pharmaceutical Co.,Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Liaoyuan City Baikang Pharmaceutical Co.,Ltd.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Shanxi Xinyu Pharmaceutical Co.,Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Shijiazhuang No.4 Pharmaceutical Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pingguang Pharmaceutical Limited

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Cardiatic Care

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Taj Pharmaceuticals

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Aditya Chemicals

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Niksan Pharmaceutical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Trumac Healthcare

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nicorandil Tablets Market

Figure 4: Global Nicorandil Tablets Market: Drivers

Figure 5: Global Nicorandil Tablets Market: Challenges

Figure 6: Global Nicorandil Tablets Market: Trends

Figure 7: Global Nicorandil Tablets Market: Opportunity

Figure 8: Global Nicorandil Tablets Market: Restraint

Figure 9: Global Nicorandil Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Nicorandil Tablets Market Value (USD Million) By Region

Figure 15: Global Nicorandil Tablets Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Nicorandil Tablets Market Value (USD Million) By Region

Figure 23: Global Nicorandil Tablets Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Nicorandil Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nicorandil Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nicorandil Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Nicorandil Tablets Market Value (USD Million) By Region

Table 10: Global Nicorandil Tablets Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Nicorandil Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Nicorandil Tablets Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Nicorandil Tablets Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Chugai Pharmaceutical Basic Information And Sales Area

Table 31: Chugai Pharmaceutical. Products Portfolio

Table 32: Henan Topfond Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 33: Henan Topfond Pharmaceutical Co.,Ltd.. Products Portfolio

Table 34: Xi`an Han Feng Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 35: Xi`an Han Feng Pharmaceutical Co.,Ltd.. Products Portfolio

Table 36: Tonghua Renmin Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 37: Tonghua Renmin Pharmaceutical Co.,Ltd.. Products Portfolio

Table 38: Liaoyuan City Baikang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 39: Liaoyuan City Baikang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 40: Shanxi Xinyu Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 41: Shanxi Xinyu Pharmaceutical Co.,Ltd.. Products Portfolio

Table 42: Shijiazhuang No.4 Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 43: Shijiazhuang No.4 Pharmaceutical Co.,Ltd.. Products Portfolio

Table 44: Pingguang Pharmaceutical Limited Basic Information And Sales Area

Table 45: Pingguang Pharmaceutical Limited. Products Portfolio

Table 46: Cardiatic Care Basic Information And Sales Area

Table 47: Cardiatic Care. Products Portfolio

Table 48: Taj Pharmaceuticals Basic Information And Sales Area

Table 49: Taj Pharmaceuticals. Products Portfolio

Table 50: Aditya Chemicals Basic Information And Sales Area

Table 51: Aditya Chemicals. Products Portfolio

Table 52: Niksan Pharmaceutical Basic Information And Sales Area

Table 53: Niksan Pharmaceutical. Products Portfolio

Table 54: Trumac Healthcare Basic Information And Sales Area

Table 55: Trumac Healthcare. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Nicorandil Tablets Market Value (USD Million) By Region

Table 61: Global Nicorandil Tablets Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Nicorandil Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	6.03 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chugai Pharmaceutical; Henan Topfond Pharmaceutical Co.,Ltd.; Xi`an Han Feng Pharmaceutical Co.,Ltd.; Tonghua Renmin Pharmaceutical Co.,Ltd.; Liaoyuan City Baikang Pharmaceutical Co.,Ltd.; Shanxi Xinyu Pharmaceutical Co.,Ltd.; Shijiazhuang No.4 Pharmaceutical Co.,Ltd.; Pingguang Pharmaceutical Limited; Cardiatic Care; Taj Pharmaceuticals; Aditya Chemicals; Niksan Pharmaceutical; Trumac Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options